Real-life evidence of how PCV20, a vaccine designed to help protect against 20 different types of pneumococcal bacteria, works in US older adults

Kudos Innovations Ltd 2026 Open access

Read full text
Authors: Pfizer Vaccines
DOI: 10.26303/jayv-7m32
Cited by: 0

Fields of Study & Subjects

Pneumonia and Respiratory Infections Bacterial Infections and Vaccines Microbial infections and disease research

Publication details

Journal / source
Kudos Innovations Ltd
Publication date
16 January 2026